miR‐33 in cardiometabolic diseases: lessons learned from novel animal models and approaches
Abstract miRNAs have emerged as critical regulators of nearly all biologic processes and
important therapeutic targets for numerous diseases. However, despite the tremendous …
important therapeutic targets for numerous diseases. However, despite the tremendous …
miR-33 in cardiometabolic diseases: lessons learned from novel animal models and approaches.
NL Price, L Goedeke, Y Suárez… - EMBO Molecular …, 2021 - europepmc.org
Abstract miRNAs have emerged as critical regulators of nearly all biologic processes and
important therapeutic targets for numerous diseases. However, despite the tremendous …
important therapeutic targets for numerous diseases. However, despite the tremendous …
[HTML][HTML] miR‐33 in cardiometabolic diseases: lessons learned from novel animal models and approaches
NL Price, L Goedeke, Y Suárez… - EMBO Molecular …, 2021 - embopress.org
Abstract miRNAs have emerged as critical regulators of nearly all biologic processes and
important therapeutic targets for numerous diseases. However, despite the tremendous …
important therapeutic targets for numerous diseases. However, despite the tremendous …
[HTML][HTML] miR‐33 in cardiometabolic diseases: lessons learned from novel animal models and approaches
NL Price, L Goedeke, Y Suárez… - EMBO Molecular …, 2021 - ncbi.nlm.nih.gov
Abstract miRNAs have emerged as critical regulators of nearly all biologic processes and
important therapeutic targets for numerous diseases. However, despite the tremendous …
important therapeutic targets for numerous diseases. However, despite the tremendous …
miR‐33 in cardiometabolic diseases: lessons learned from novel animal models and approaches
NL Price, L Goedeke, Y Suárez… - EMBO Molecular …, 2021 - search.proquest.com
Abstract miRNAs have emerged as critical regulators of nearly all biologic processes and
important therapeutic targets for numerous diseases. However, despite the tremendous …
important therapeutic targets for numerous diseases. However, despite the tremendous …
miR-33 in cardiometabolic diseases: lessons learned from novel animal models and approaches
NL Price, L Goedeke, Y Suárez… - EMBO molecular …, 2021 - pubmed.ncbi.nlm.nih.gov
miRNAs have emerged as critical regulators of nearly all biologic processes and important
therapeutic targets for numerous diseases. However, despite the tremendous progress that …
therapeutic targets for numerous diseases. However, despite the tremendous progress that …
[HTML][HTML] miR‐33 in cardiometabolic diseases: lessons learned from novel animal models and approaches
NL Price, L Goedeke, Y Suárez… - EMBO Molecular …, 2021 - embopress.org
Abstract miRNAs have emerged as critical regulators of nearly all biologic processes and
important therapeutic targets for numerous diseases. However, despite the tremendous …
important therapeutic targets for numerous diseases. However, despite the tremendous …
miR-33 in cardiometabolic diseases: lessons learned from novel animal models and approaches.
NL Price, L Goedeke, Y Suárez… - EMBO Molecular …, 2021 - europepmc.org
Abstract miRNAs have emerged as critical regulators of nearly all biologic processes and
important therapeutic targets for numerous diseases. However, despite the tremendous …
important therapeutic targets for numerous diseases. However, despite the tremendous …
miR‐33 in cardiometabolic diseases: lessons learned from novel animal models and approaches
NL Price, L Goedeke, Y Suárez… - EMBO Molecular …, 2021 - search.proquest.com
Abstract miRNAs have emerged as critical regulators of nearly all biologic processes and
important therapeutic targets for numerous diseases. However, despite the tremendous …
important therapeutic targets for numerous diseases. However, despite the tremendous …